Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB2 | P62993 | 1/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 6/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 6/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16340699 | 0.96 | GRB2 (0.49) | GRB2CAPN1NTSR2NTSR1SLC6A2 | |
| SCHEMBL12237948 | 0.91 | CXCR4 (0.49) | GRB2CAPN1 | |
| SCHEMBL16351063 | 0.89 | GRB2 (0.47) | GRB2CAPN1NTSR2NTSR1SLC6A2 | |
| SCHEMBL29629087 | 0.83 | MAPK8 (0.46) | — | |
| SCHEMBL24485881 | 0.83 | MAPK8 (0.46) | — | |
| SCHEMBL31542148 | 0.83 | NTSR2 (0.52) | CAPN1NTSR2NTSR1SLC6A2SORT1 | |
| SCHEMBL31542147 | 0.82 | NTSR2 (0.51) | CAPN1NTSR2NTSR1SLC6A2SORT1 | |
| SCHEMBL31018311 | 0.82 | CXCR4 (0.47) | OPRD1 | |
| SCHEMBL31018315 | 0.81 | NMUR2 (0.49) | CAPN1NTSR2NTSR1SORT1 | |
| SCHEMBL31018335 | 0.81 | CXCR4 (0.48) | OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263739-B2 | also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis | BRACCO SUISSE SA (CH) | 2012-09-11 | — | — | US | disclosed |